Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Harvard Business School
Dow
Medtronic
US Army
Moodys
Covington
Deloitte
QuintilesIMS

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018243

« Back to Dashboard

NDA 018243 describes OXYTOCIN, which is a drug marketed by Fresenius Kabi Usa, Hikma Farmaceutica, Teva Pharms Usa, West-ward Pharms Int, and Abbott, and is included in five NDAs. It is available from five suppliers. Additional details are available on the OXYTOCIN profile page.

The generic ingredient in OXYTOCIN is oxytocin. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxytocin profile page.
Summary for 018243
Tradename:OXYTOCIN
Applicant:West-ward Pharms Int
Ingredient:oxytocin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018243
Medical Subject Heading (MeSH) Categories for 018243
Suppliers and Packaging for NDA: 018243
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OXYTOCIN oxytocin INJECTABLE;INJECTION 018243 NDA West-Ward Pharmaceutical Corp. 0641-6114 N 0641-6114-25
OXYTOCIN oxytocin INJECTABLE;INJECTION 018243 NDA West-Ward Pharmaceutical Corp. 0641-6115 N 0641-6115-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10USP UNITS/ML (10USP UNITS/ML)
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength100USP UNITS/10ML (10USP UNITS/ML)
Approval Date:Jan 10, 2007TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Julphar
Citi
Dow
Teva
Cantor Fitzgerald
Cipla
Argus Health
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.